Home
Resource
Gauging the psychological impact of counseling patients with BRCA1/2, CDH1, TP53, and Lynch Syndrome pathogenic variants on genetic counselors in the cancer setting
PDF
PDF format is widely accepted and good for printing.
Plug-in required
PDF-1(463.93 kb)
Citation & Export
View Usage Statistics
Staff View

Citation & Export
Hide

Simple citation

Emery, Matthew. Gauging the psychological impact of counseling patients with BRCA1/2, CDH1, TP53, and Lynch Syndrome pathogenic variants on genetic counselors in the cancer setting. Retrieved from https://doi.org/doi:10.7282/t3-pmx8-zj20

Export

Click here for information about Citation Management Tools at Rutgers.

Statistics
Hide

Description

TitleGauging the psychological impact of counseling patients with BRCA1/2, CDH1, TP53, and Lynch Syndrome pathogenic variants on genetic counselors in the cancer setting
NameEmery, Matthew (author); Joines, Jessica (chair); Grumet, Sherry (internal member); D'Elia, Sandra (internal member); Rutgers University; School of Graduate Studies
Date Created2021
Other Date2021-05 (degree)
SubjectMicrobiology and Molecular Genetics, Genetic counseling
Extent1 online resource (iv, 44 pages) : illustrations
DescriptionGenetic counselors (GCs) in the cancer setting are involved to the repeat exposure of discussing life-altering management recommendations for individuals who test positive for pathogenic mutations in cancer susceptibility genes. This study attempted to characterize the short- and long-term psychological impact GCs may experience as a result of repeat exposure to discussing management recommendations associated with pathogenic mutations in BRCA1/2, CDH1, TP53 and Lynch syndrome by surveying GCs in the cancer setting. Our study showed that GCs experience an increase in anxious feelings and sadness, and have concerns about variant penetrance prior to counseling patients with positive test results. We discovered that there are significantly increased levels of anxious feelings, sadness and penetrance concerns when counseling patients on pathogenic mutations in CDH1 and TP53 versus BRCA1/2 and Lynch syndrome. This effect appears to be tempered by time in practice as well as access to coping strategies including access to other GCs.
NoteM.S.
NoteIncludes bibliographical references
Genretheses, ETD graduate
Persistent URLhttps://doi.org/doi:10.7282/t3-pmx8-zj20
LanguageEnglish
CollectionSchool of Graduate Studies Electronic Theses and Dissertations
Organization NameRutgers, The State University of New Jersey
RightsThe author owns the copyright to this work.
Version 8.5.5
Rutgers University Libraries - Copyright ©2024